Evidence map›Paper›PMID 36043382›Full record

Observational studyEpidemiology and infection2021

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.

Gen Yamada, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Hiroshi Ohtsu, Ako Toyoda, Koji Kitajima, Shinya Tsuzuki and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Epidemiology and infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Gen YamadaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0001-9433-4287
Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Nobuaki MatsunagaAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Mari TeradaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Setsuko SuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yusuke AsaiAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroshi OhtsuCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Ako ToyodaCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Koji KitajimaCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Shinya TsuzukiAMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0001-5732-846X
Sho SaitoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
National Center for Global Health and Medicine · JPUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting the need for hospitalisation of patients with coronavirus disease 2019 (COVID-19) is important for preventing healthcare disruptions. This observational study aimed to use the COVID-19 Registry Japan (COVIREGI-JP) to develop a simple scoring system to predict respiratory failure due to COVID-19 using only underlying diseases and symptoms. A total of 6873 patients with COVID-19 admitted to Japanese medical institutions between 1 June 2020 and 2 December 2020 were included and divided into derivation and validation cohorts according to the date of admission. We used multivariable logistic regression analysis to create a simple risk score model, with respiratory failure as the outcome for young (18-39 years), middle-aged (40-64 years) and older (≥65 years) groups, using sex, age, body mass index, medical history and symptoms. The models selected for each age group were quite different. Areas under the receiver operating characteristic curves for the simple risk score model were 0.87, 0.79 and 0.80 for young, middle-aged and elderly derivation cohorts, and 0.81, 0.80 and 0.67 in the validation cohorts. Calibration of the model was good. The simple scoring system may be useful in the appropriate allocation of medical resources during the COVID-19 pandemic.

Indexed as

COVID-19Respiratory InsufficiencyAgedHospitalizationHumansJapanMiddle AgedPandemicsRetrospective StudiesCOVID-19prediction modelrespiratory failurerisk scoring

Identifiers

PMID36043382
PMCPMC8365048
OpenAlexW3188421644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.